(Reuters) -President Donald Trump's administration is preparing a new probe into drug pricing practices among U.S. trading ...

As part of the deal, some of Pfizer’s drugs will be offered in the United States through a direct-to-consumer website, ...

Cost Plus Drugs Co-Founder Mark Cuban is all in on adding Cost Plus to the TrumpRx platform. In a 30-min exclusive interview ...

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...

President Trump says his administration will "dramatically slash the cost of IVF" by negotiating lower drug prices, though ...

Trump’s 100 percent tariff on drugs may force some manufacturing onshore, and it may create some domestic jobs that wouldn’t ...

Just as pharmaceutical tariff uncertainty seemed to be easing in the U.S., the Trump administration is reportedly staging a ...

Several drug pricing experts say without key details, it’s hard to call the individual pharma deals a win for the Trump administration.

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...

President Donald Trump is planning to launch a new investigation into drug prices aimed at ensuring foreign countries pay as ...

Aurobindo Pharma derives 89 per cent of its revenue from exports, with nearly half (49 per cent) from the US. Similarly, ...